MAYERSOHN JOEL DAVID reported 1 transaction at CITIUS ONCOLOGY, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/7/2025ACC: 0001213900-25-073136
Director
Since Oct 2022
+21.23K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
21.23K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+21.23K
Price / share
—
Trade value
—
% of position
New position
7/28/2025
0.00→21.23K
Total
Net shares
+21.23K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/28/2025 | J · J | +21.23K | — | — | New position | 0.00 | 21.23K |
| Total | +21.23K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)1
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
250K
Shares owned
250K
Exercise price
1.07
Expiration
—
Exercise window
—
Total
Underlying
250K
Owned
250K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 1.07 | — | — | 250K | 250K |
| Total | 250K | 250K | ||||